In the Lab By Sharon Begley DNA sleuths read the coronavirus genome, tracing its origins and looking for dangerous mutations
Heavyweights By Usha Lee McFarling Near the campus cow pasture, a scientist works to grow human organs — in pigs
In the Lab By Sharon Begley Gene-editing discovery could point the way toward a ‘holy grail’: cures for mitochondrial diseases
Health By Sharon Begley New CRISPR-based test for Covid-19 could be a simple, cheap at-home diagnostic, scientists say
In the Lab By Sharon Begley In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys
In the Lab By Sharon Begley You had questions for David Liu about CRISPR, prime editing, and advice to young scientists. He has answers
Health By Rebecca Robbins, Damian Garde, and Adam Feuerstein ‘Science is very much a part of culture’: Siddhartha Mukherjee dives into the history of genetics in a new Ken Burns film
First Opinion By Neal Baer Covid-19 is scary. Could a rogue scientist use CRISPR to conjure another pandemic?
In the Lab By Associated Press In its first use inside the human body, CRISPR genome editing tested as blindness therapy
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Biohacker Josiah Zayner on getting canceled, good news in cancer, and a long road in Ebola
First Opinion By Josiah Zayner CRISPR babies scientist He Jiankui should not be villainized — or headed to prison
First Opinion By Josephine Johnston He Jiankui is going to jail. Would the U.S. criminally prosecute a rogue gene-editing researcher?
Don't Miss By STAT staff What will 2020 bring for medicine and science? We asked 16 leaders for predictions
In the Lab By Sharon Begley Creating Pig3.0, the world’s most CRISPR’d animal, raises hopes of transplantable organs
Biotech By Sharon Begley and Adam Feuerstein First CRISPR treatment for blood diseases shows early benefits in two patients
Business By Adam Feuerstein and Damian Garde This is awkward: Genome editing startup Beam has competition — from one of its own cofounders
In the Lab By Sharon Begley New CRISPR tool has the potential to correct almost all disease-causing DNA glitches, scientists report
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Pharma’s future in China, CRISPR meets Netflix, & where VC dollars come from
In the Lab By Olga Dobrovidova Calling embryo editing ‘premature,’ Russian authorities seek to ease fears of a scientist going rogue
Don't Miss By Sharon Begley What’s in the cards for this year’s Nobel Prizes? Scientists are placing their bets
In the Lab By Rebecca Robbins Major error undermines study suggesting change introduced in the CRISPR babies experiment shortens lives
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Vaping upheaval, DNA test dynamics, & the future of genome editing
Health By Sharon Begley ‘I just want to live’: California man pleads with scientists around the world to ‘CRISPR me’
First Opinion By Francoise Baylis Before heritable genome editing, we need slow science and dialogue ‘within and across nations’
Health By Andrew Joseph Could editing the DNA of embryos with CRISPR help save people who are already alive?
Health By Sharon Begley In a CRISPR first, therapy intended to cure HIV patient appears safe — though ineffective
In the Lab By Sharon Begley Why so many cancer drugs fail: Genes thought ‘essential’ for tumor survival are not, study finds
Business By Sharon Begley Battleground narrowed in CRISPR patent case between University of California and Broad